Physician
Cardiology
Dr. George A. Diamond, MD
|
|
Give Review
George Diamond is an expert in the field of Cardiology. He researched medicine at Drexel University College of Medicine. He received awards:"Fellow (FACC)". George Diamond has written publications. He has 52 publications published with PubMed. The lastest publication is: 'A Kinetic Model for the Integrated Assessment of Safety and Efficacy in Clinical Trials.'
Publications
- A Kinetic Model for the Integrated Assessment of Safety and Efficacy in Clinical Trials.
- Randomized Trials, Observational Registries, and the Foundations of Evidence-Based Medicine.
- Risk and the Physics of Clinical Prediction.
- Letter by diamond regarding article, "bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main ...
- Forbidden Fruit: On the Analysis of Recurrent Events in Randomized Clinical Trials.
- On Reporting of Effect Size in Randomized Clinical Trials.
- Improved Prospects for IVUS in Identifying Vulnerable Plaques?
- Right answer, wrong question: on the clinical relevance of the cardiovascular history.
- Should everolimus-eluting stents be preferred in patients with acute and stable coronary syndromes?
- Erratum to: The JUPITER Trial: Myth or Reality?
- The JUPITER Trial: Myth or Reality?
- Medical device regulatory reform: insights from the watchman left atrial appendage closure technology for stroke prophylaxis in atrial fibrillation.
- Gone Fishing!: On the "Real-World" Accuracy of Computed Tomographic Coronary Angiography: Comment on "Ontario Multidetector Computed Tomographic Coronary Angiography S...
- ACCF/AHA New Insights Into the Methodology of Performance Measurement.
- What the Tortoise said to Achilles.
- By Jove! What is a clinician to make of JUPITER?
- Prasugrel and cancer: an uncertain association or a credible risk that meaningfully alters the benefit-risk balance.
- Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium?
- How would the Reverend Bayes interpret high-sensitivity troponin?
- ObamaCare.
- Trial and error. How to avoid commonly encountered limitations of published clinical trials.
- Statins in acute coronary syndromes: do the guideline recommendations match the evidence?
- Bayesian classification of clinical practice guidelines.
- A 300-year-old solution to the health care crisis.
- Intravascular ultrasound tissue characterization: messages from the heart.
- Evidence-based financial incentives for healthcare reform: putting it together.
- Cost, effectiveness, and cost-effectiveness.
- The disconnect between practice guidelines and clinical practice--stressed out.
- Rosiglitazone and cardiovascular risk.
- Simvastatin with or without ezetimibe in familial hypercholesterolemia.
- DTCA for PTCA--crossing the line in consumer health education?
- Predicting cardiovascular events with coronary calcium scoring.
- Prevention and treatment: a tale of two strategies.
- Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death.
- COURAGE under fire: on the management of stable coronary disease.
- As time goes by: current status and future directions in the controversy over stenting.
- Screen testing cardiovascular prevention in asymptomatic diabetic patients.
- The things to come of SHAPE: cost and effectiveness of cardiovascular prevention.
- Role of clopidogrel in managing atherothrombotic cardiovascular disease.
- An orwellian discourse on the meaning and measurement of noninferiority.
- Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
- From here to eternity: a unified kinetic model for the pathophysiology of atherosclerotic events.
- Current status and future trends in drug-eluting stents.
- Good enough: a primer on the analysis and interpretation of noninferiority trials.
- Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence.
- Hazardous to your health: kinetic foundations of risk stratification and therapeutic triage.
- Trials and tribulations of non-inferiority: the ximelagatran experience.
- Prospective validation of a quantitative method for differentiating ischemic versus nonischemic cardiomyopathy by technetium-99m sestamibi myocardial perfusion single-...
- Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials.
- Usefulness of finger blood flow during exercise as a marker of functionally significant coronary heart disease.
- Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography.
Schools
Drexel University College of Medicine
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Cedars-Sinai Medical Center -
Drexel University College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Faye M. Montegrande, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Guy S. Mayeda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan M. Tobis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Cruz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shahid H. Khan, MD |
|
|
Dr. Satinder P. Sidhu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nidhi Thareja, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jayson A. Morgan, MD |
|
|
Dr. Jennifer L. Nguyen, MD |
|
|
Dr. Suresh P. Rao, MD |
|
|
Dr. Suresh P. Rao, MD |